234 related articles for article (PubMed ID: 17911190)
1. Elevated concentrations of soluble adhesion molecules and large platelets in diabetic patients: are they markers of vascular disease and diabetic nephropathy?
Bavbek N; Kargili A; Kaftan O; Karakurt F; Kosar A; Akcay A
Clin Appl Thromb Hemost; 2007 Oct; 13(4):391-7. PubMed ID: 17911190
[TBL] [Abstract][Full Text] [Related]
2. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
Tan KT; Tayebjee MH; Lim HS; Lip GY
Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
[TBL] [Abstract][Full Text] [Related]
3. Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes.
Glowinska B; Urban M; Peczynska J; Florys B
Metabolism; 2005 Aug; 54(8):1020-6. PubMed ID: 16092051
[TBL] [Abstract][Full Text] [Related]
4. Increased soluble E-selectin levels in type 2 diabetic patients with peripheral arterial disease.
Boulbou MS; Koukoulis GN; Vasiou KG; Petinaki EA; Gourgoulianis KI; Fezoulidis IB
Int Angiol; 2004 Mar; 23(1):18-24. PubMed ID: 15156125
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil surface expression of CD11b and CD62L in diabetic microangiopathy.
Mastej K; Adamiec R
Acta Diabetol; 2008 Sep; 45(3):183-90. PubMed ID: 18496641
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of soluble E-selectin in diabetic patients with severe symptomatic peripheral arterial occlusive disease requiring angioplasty. A possible role in diabetic vascular disease?
Elhadd TA; Kennedy G; McLaren M; Stonebridge PA; Shaw WJ; Belch JJ
Int Angiol; 2000 Jun; 19(2):171-5. PubMed ID: 10905802
[TBL] [Abstract][Full Text] [Related]
7. Elevation of serum soluble E- and P-selectin in patients with hypertension is reversed by benidipine, a long-acting calcium channel blocker.
Sanada H; Midorikawa S; Yatabe J; Yatabe MS; Katoh T; Baba T; Hashimoto S; Watanabe T
Hypertens Res; 2005 Nov; 28(11):871-8. PubMed ID: 16555575
[TBL] [Abstract][Full Text] [Related]
8. Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus.
Omoto S; Nomura S; Shouzu A; Nishikawa M; Fukuhara S; Iwasaka T
Diabetologia; 2002 Apr; 45(4):550-5. PubMed ID: 12032632
[TBL] [Abstract][Full Text] [Related]
9. [Selectins in the pathogenesis and diagnosis of early atherosclerotic changes in children and adolescents with risk factors (obesity, hypertension and diabetes)].
Głowińska B; Urban M; Peczyńska J; Florys B
Przegl Lek; 2004; 61(9):935-9. PubMed ID: 15803902
[TBL] [Abstract][Full Text] [Related]
10. [Levels of soluble adhesion molecules among normal and hypertensive type 2 diabetic patients].
Rubio-Guerra AF; Vargas-Robles H; Medina-Santillán R; Escalante-Acosta BA
Gac Med Mex; 2008; 144(1):11-4. PubMed ID: 18619052
[TBL] [Abstract][Full Text] [Related]
11. Nephropathy in type 1 diabetes is associated with increased circulating activated platelets and platelet hyperreactivity.
Tarnow I; Michelson AD; Barnard MR; Frelinger AL; Aasted B; Jensen BR; Parving HH; Rossing P; Tarnow L
Platelets; 2009 Nov; 20(7):513-9. PubMed ID: 19852691
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of selectins in kidneys of patients with diabetic nephropathy.
Hirata K; Shikata K; Matsuda M; Akiyama K; Sugimoto H; Kushiro M; Makino H
Diabetologia; 1998 Feb; 41(2):185-92. PubMed ID: 9498652
[TBL] [Abstract][Full Text] [Related]
13. [Alterations of platelet membrane glycoproteins in patients with diabetes mellitus and their clinical significance].
Han Y; Wang Z; Wang A
Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):127-9. PubMed ID: 11601237
[TBL] [Abstract][Full Text] [Related]
14. Markers of endothelial dysfunction in the prediction of coronary artery disease in type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study.
Costacou T; Lopes-Virella MF; Zgibor JC; Virella G; Otvos J; Walsh M; Orchard TJ
J Diabetes Complications; 2005; 19(4):183-93. PubMed ID: 15993351
[TBL] [Abstract][Full Text] [Related]
15. Mean platelet volume in patients with type 2 diabetes mellitus.
Papanas N; Symeonidis G; Maltezos E; Mavridis G; Karavageli E; Vosnakidis T; Lakasas G
Platelets; 2004 Dec; 15(8):475-8. PubMed ID: 15763888
[TBL] [Abstract][Full Text] [Related]
16. Coronary heart disease is associated with mean platelet volume in type 2 diabetic patients.
Tavil Y; Sen N; Yazici H; Turfan M; Hizal F; Cengel A; Abaci A
Platelets; 2010; 21(5):368-72. PubMed ID: 20521863
[TBL] [Abstract][Full Text] [Related]
17. Soluble P-selectin as a marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease.
Ferroni P; Basili S; Martini F; Vieri M; Labbadia G; Cordova C; Alessandri C; Gazzaniga PP
J Investig Med; 2000 Jan; 48(1):21-7. PubMed ID: 10695266
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of plasma CD146 and P-selectin in patients with type 2 diabetic nephropathy.
Wang F; Xing T; Wang N; Liu L
Cytokine; 2012 Jan; 57(1):127-9. PubMed ID: 22088599
[TBL] [Abstract][Full Text] [Related]
19. Rheological changes in diabetic microangiopathy.
Negrean V; Suciu I; Sâmpelean D; Cozma A
Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
[TBL] [Abstract][Full Text] [Related]
20. T-cell cytokine production and endothelial dysfunction in type 2 diabetic patients with nephropathy.
Kamel L; Morsy A; El Shamaa A
East Mediterr Health J; 2009; 15(4):807-16. PubMed ID: 20187532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
